2-174571720-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001375834.1(WIPF1):c.1085G>A(p.Ser362Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S362G) has been classified as Uncertain significance.
Frequency
Consequence
NM_001375834.1 missense
Scores
Clinical Significance
Conservation
Publications
- Wiskott-Aldrich syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- Wiskott-Aldrich syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001375834.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| WIPF1 | NM_001375834.1 | MANE Select | c.1085G>A | p.Ser362Asn | missense | Exon 5 of 8 | NP_001362763.1 | ||
| WIPF1 | NM_001375835.1 | c.1085G>A | p.Ser362Asn | missense | Exon 5 of 9 | NP_001362764.1 | |||
| WIPF1 | NM_001077269.1 | c.1085G>A | p.Ser362Asn | missense | Exon 5 of 8 | NP_001070737.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| WIPF1 | ENST00000679041.1 | MANE Select | c.1085G>A | p.Ser362Asn | missense | Exon 5 of 8 | ENSP00000503603.1 | ||
| WIPF1 | ENST00000272746.9 | TSL:1 | c.1085G>A | p.Ser362Asn | missense | Exon 5 of 9 | ENSP00000272746.5 | ||
| WIPF1 | ENST00000359761.7 | TSL:1 | c.1085G>A | p.Ser362Asn | missense | Exon 5 of 8 | ENSP00000352802.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000798 AC: 2AN: 250622 AF XY: 0.00000737 show subpopulations
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461844Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 727216 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Wiskott-Aldrich syndrome 2 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces serine with asparagine at codon 362 of the WIPF1 protein (p.Ser362Asn). The serine residue is weakly conserved and there is a small physicochemical difference between serine and asparagine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with WIPF1-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The asparagine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at